1. Home
  2. SGRP vs ENLV Comparison

SGRP vs ENLV Comparison

Compare SGRP & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.89

Market Cap

27.3M

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

SELL

Current Price

$1.09

Market Cap

26.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SGRP
ENLV
Founded
1967
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.3M
26.6M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
SGRP
ENLV
Price
$0.89
$1.09
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$7.00
AVG Volume (30 Days)
61.0K
11.2M
Earning Date
11-14-2025
11-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,130,000.00
N/A
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.79
N/A
52 Week Low
$0.85
$0.83
52 Week High
$2.28
$2.10

Technical Indicators

Market Signals
Indicator
SGRP
ENLV
Relative Strength Index (RSI) 35.44 58.56
Support Level $0.87 $0.89
Resistance Level $0.92 $1.06
Average True Range (ATR) 0.06 0.14
MACD -0.01 0.01
Stochastic Oscillator 16.35 26.43

Price Performance

Historical Comparison
SGRP
ENLV

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: